Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sukanta Satapathy"'
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 12, Iss 2, Pp 298-308 (2022)
Tyrosine kinase inhibitors (TKIs) are used as targeted therapy for cancer by inhibiting the signaling pathway and tumor growth. Many TKIs got approved by FDA in recent times for the treatment of cancer by oral route. However, the TKIs have formulatio
Externí odkaz:
https://doaj.org/article/55c134963dd146d6ab3ffd988401405c
Autor:
null Sukanta Satapathy
Publikováno v:
Journal of Pharmaceutical Negative Results. :3643-3649
Cancer is a threat to humanity in this era. The new cases are sharply increasing. The cancer death also a major problem of the recent time. In this review the various treatment options available are described. The cancer types also explained. The WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc8a49e3d1bf0a45b30cabf7cadd557f
https://doi.org/10.47750/pnr.2023.14.02.429
https://doi.org/10.47750/pnr.2023.14.02.429
Autor:
Laxmidhar Sahoo, Goutam Kumar Jena, Chandra Sekhar Patro, Ch.Niranjan Patro, Sukanta Satapathy
Publikováno v:
Journal of Pharmaceutical Innovation. 17:1405-1419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b23897a1ba36042dfda76b4e38c8e64
https://doi.org/10.1007/s12247-022-09675-5
https://doi.org/10.1007/s12247-022-09675-5
Publikováno v:
Asian Pacific Journal of Health Sciences. 9:46-55
The nano drug delivery system has emerged as a novel therapeutic approach for improved efficacy of the existing drug molecules. Polymeric nanoparticles, lipid based nanoparticles such as solid lipid nanoparticles (SLNs), nanostructured lipid carriers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18e44276ed4362cb4fade47c5e868495
https://doi.org/10.21276/apjhs.2022.9.4.11
https://doi.org/10.21276/apjhs.2022.9.4.11
Autor:
Sukanta Satapathy, Ch. Niranjan Patro, Goutam Kumar Jena, Chandra Sekhar Patro, Laxmidhar Sahoo
Publikováno v:
Journal of Pharmaceutical Research International. :49-76
Background: The advanced development of lipid nanocarrier contributes a lot to the domain of therapeutic effectiveness of the drug. However the parameter such as drug loading, drug release, stability, and targeting influence much more towards the lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::559e0d1dca9bbd201952682ae7ecff90
https://doi.org/10.9734/jpri/2022/v34i17b35771
https://doi.org/10.9734/jpri/2022/v34i17b35771
Publikováno v:
Advanced pharmaceutical bulletin. 12(2)
Tyrosine kinase inhibitors (TKIs) are used as targeted therapy for cancer by inhibiting the signaling pathway and tumor growth. Many TKIs got approved by FDA in recent times for the treatment of cancer by oral route. However, the TKIs have formulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1866782671205c58c895ef1c5a0c07
https://pubmed.ncbi.nlm.nih.gov/35620346
https://pubmed.ncbi.nlm.nih.gov/35620346
Autor:
Satapathy, Sukanta1 (AUTHOR), Kunam, Aishwarya2 (AUTHOR), Rashme, Rashme3 (AUTHOR), Sudarsanam, Pooja3 (AUTHOR), Gupta, Anuj4 (AUTHOR), Kiran Kumar, H5 (AUTHOR)
Publikováno v:
Journal of Pharmacy & Bioallied Sciences. 2024 Suppl, Vol. 16, p939-941. 3p.
Autor:
Satapathy, Sukanta1 sukanta.satapathy@cutm.ac.in, Patro, Chandra Sekhar1
Publikováno v:
Advanced Pharmaceutical Bulletin. 2022, Vol. 12 Issue 2, p298-308. 11p.
Autor:
Sahoo, Laxmidhar, Jena, Goutam Kumar, Patro, Chandra Sekhar, Patro, Ch.Niranjan, Satapathy, Sukanta
Publikováno v:
Journal of Pharmaceutical Innovation; Dec2022, Vol. 17 Issue 4, p1405-1419, 15p